Aggregated China Business Blogs



Tongjitang's Osteoperosis Drug Likely to Win FDA Approval

Aggregated Source: Seeking Alpha China stocks
October 31, 2007|

Tongjitang Pharmaceuticals (NYSE:TCM) announced its mainstay traditional Chinese medicine for osteoporosis, Xianling Gubao, was effective in a two-year trial.

Original URL: Click here to visit original article
Copyright Seeking Alpha China stocks

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Sunway and Genzyme to Collaborate on Gene Therapy
  • Benda's Jiangling Plant Receives Production Approval
  • SFDA: Only Four Chinese Drug Retail Websites Are Legal
  • SFDA: Only Four Chinese Drug Retail Websites Are Legal
  • SFDA: Only Four Chinese Drug Retail Websites Are Legal

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |